Clinical trials
Phase 2 Hypercholesterolemia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 8 |
| 2012 | 2 |
| 2013 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| Regeneron Pharmaceuticals | 3 |
| University of Toronto | 3 |
| Pfizer | 2 |
| Catabasis Pharmaceuticals | 1 |
| DNP Canada | 1 |
| Eli Lilly and Company | 1 |
| Esperion Therapeutics, Inc. | 1 |
| Glycemic Index Laboratories, Inc | 1 |
| Micropharma Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 25 |
| Hyperlipidemias | 6 |
| Dyslipidemias | 5 |
| Cardiovascular Diseases | 4 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypertriglyceridemia | 2 |
| Acute Coronary Syndrome | 1 |
| Coronary Disease | 1 |
| Diabetes Mellitus | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.